This study delves into the genetic underpinnings of pediatric sepsis, focusing on the association and potential mechanisms of action of four key genes: RGL4, ATP9A, MAP3K7CL, and DDX11L2. Utilizing a combination of differential expression analysis, Mendelian Randomization (MR), immune cell infiltration analysis, and validation through independent datasets, we aimed to elucidate the roles these genes play in the pathophysiology of sepsis and their implications for immune response modulation. Our findings reveal that RGL4 and ATP9A are upregulated in sepsis cases, suggesting their involvement in exacerbating the condition through the promotion of inflammatory responses. Conversely, MAP3K7CL and DDX11L2 are downregulated, indicating their potential protective effects against sepsis by modulating immune responses and preventing excessive inflammation. The MR analysis, particularly employing the Inverse Variance Weighted method, provided evidence for the causal relationship between these genes and sepsis risk, highlighting their significance in the disease's genetic landscape. These genes represent promising biomarkers for sepsis risk stratification and prognosis, offering new avenues for early detection and personalized treatment strategies. This research contributes to the understanding of the genetic factors influencing pediatric sepsis and opens up potential pathways for the development of targeted therapeutic interventions, aiming to improve patient outcomes in this challenging clinical condition.